Skip to main content

Advertisement

Log in

Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study

International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

Background

Several fatal cases of bodybuilders, following a myocardial infarction after long exposure to androgenic-anabolic steroids (AAS), are reported. In recent years, evidence has emerged of cases of heart failure related to AAS consumption, with no signs of coronary or aorta atherosclerosis. This study aims to further investigate the pathogenesis of the ventricular AAS-related remodeling performing immunohistochemistry (IHC).

Method

In order to examine innate immunity activity and myocytes and endothelial cell apoptosis, IHC analyses were performed on heart tissue of two cases of bodybuilders who died after years of supratherapeutic use of metelonone and nandrolone and where no atherosclerosis or thrombosis were found, using the following antibodies: anti-CD68, anti-iNOS, anti-CD163, anti-CD 15, anti-CD8, anti-CD4, anti-HIF1 α, and in situ TUNEL staining.

Results

Results confirm the experimental findings of recent research that, in the absence of other pathological factors, if intensive training is combined with AAS abuse, myocytes and endothelial cells undergo apoptotic alterations. The absence of inflammatory reactions and the presence of an increased number of M2 macrophages in the areas of fibrotic remodeling confirm that the fibrotic changes in the heart are apoptosis-related and not necrosis-related.

Conclusions

In conclusion, the study indicates that, in very young subjects with chronic hypoxia-related alterations of the heart, signs of a heart failure in the other organs and a history of AAS abuse, death can be ascribed to progressive heart failure due to the direct apoptotic cardiac and endothelial changes produced by AAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. World Anti-Doping Agency (2014) Anti-doping testing figures report. www.wada-ama.org

  2. Parkinson AB, Evans NA (2008) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exer 38:644–651

    Article  Google Scholar 

  3. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15

    Article  CAS  PubMed  Google Scholar 

  4. Madea B, Grellner W (1998) Long-term cardiovascular effects of anabolic steroids. Lancet 352:33

    Article  CAS  PubMed  Google Scholar 

  5. Madea B, Grellner W, Musshoff F, Dettmeyer R (1998) Medico-legal aspects of doping. J Clin Forensic Med 5(1):1–7

    Article  CAS  PubMed  Google Scholar 

  6. McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ (1988) Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 62:164

    Article  CAS  PubMed  Google Scholar 

  7. Ferenchick GS, Adelman S (1992) Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124:507–508

    Article  CAS  PubMed  Google Scholar 

  8. Papamitsou T, Barlagiannis D, Papaliagkas V, Kotanidou E, Dermentzopoulou-Theodoridou M (2011) Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells—an ultrastructural and immunohistochemical study. Med Sci Monit 17:266–273

    Article  Google Scholar 

  9. Fineschi V, Baroldi G, Monciotti F, Pagliacci Reattelli L, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death. Arch Pathos Lab Med 125:253–255

    CAS  Google Scholar 

  10. Montisci M, El Mazloum R, Cecchetto G, Terranova C, Ferrara SD, Thiene G, Basso C (2012) Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 217:1–3

    Article  Google Scholar 

  11. Thiblin I, Mobini-Far H, Frisk M (2009) Sudden unexpected death in a female fitness athlete with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Sci Int 184:1–3

    Article  Google Scholar 

  12. Luke JL, Farb A, Virmani R, Sample RHB (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. J Forensic Sci 35:1441–1447

    Article  CAS  PubMed  Google Scholar 

  13. Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Legal Med 111:261–264

    Article  CAS  PubMed  Google Scholar 

  14. Robbins SL, Cotran RS (2015) In: Kumar, Abbas, Aster (eds) Pathologic basis of disease, Ninth edn. Elsevier, Amsterdam

    Google Scholar 

  15. Mobini Far HZ, Ågren G, Thiblin I (2012) Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings. Cardiovasc Pathol 21(4):312–316

    Article  Google Scholar 

  16. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Pope Long HG (2010) Term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 3:472–476

    Article  PubMed  PubMed Central  Google Scholar 

  17. D’Andrea A, Caso P, Salerno G, Scarafile R, De Corato G, Mita C, Di Salvo G, Severino S, CuomoS LB, Esposito N, Calabro R (2007) Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis. Br J Sports Med 41:149–155

    Article  PubMed  Google Scholar 

  18. Zaugg M, Jamali NZ, Lucchinetti E, Xu W, Alam M, Shafiq SA, Siddiqui MAQ (2001) Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 187:90–95

    Article  CAS  PubMed  Google Scholar 

  19. Montisci R, Cecchetto G, Ruscazio M, Snenghi R, Portale A,Viel G, Nalesso A, Paoli A, Illiceto S, Meloni L, Ferrara SD, Montisci M (2010) Early myocardial dysfunction after chronic use of anabolic androgenic steroids: combined pulsed-wave tissue doppler imaging and ultrasonic integrated backscatter cyclic variations analysis. J Am Soc Echocardiogr 23:516–522

  20. Luijkx T, Velthuis BK, Backx FJ, Buckens CF, Prakken NH, Rienks R, Mali WP, Cramer MJ (2013) Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol 167:664–8

  21. Angell PJ, Ismail TF, Jabbour A, Smith G, Dahl A, Wage R, Whyte G, Green DJ, Prasad S, George K (2014) Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study. Eur J Appl Physiol 114:921–8

  22. Scarabelli TM, Stephanou A, Pasini E, Comini L, Raddino R, Knight RA, Latchman DS (2002) Different Signaling Pathways Induce Apoptosis in Endothelial Cells and Cardiac Myocytes During Ischemia/Reperfusion Injury. Circulation Research 90:745–748

  23. Saraste A, Pulkki K, Kallajoki M, Heikkilä P, Laine P, Mattila S, Nieminen MS,  Parvinen M, Voipio-Pulkki LM (1990) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 9:380–386

  24. Fantona L, Belhanib D, Vaillantb F, Tabiba A, Gomezc L, Descotesd J, Dehinab L, Bui-Xuanb B, Maliciera D, Timourb Q (2009) Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Exp Toxicol Pathol 61:317–323

  25. Condorelli G, Roncarati R, Ross J, Pisani A, Stassi G, Todaro M, Trochai S, Drusco A,  Gu Y,  Russo MA, Frati G, Jonesi SP, Leferi DJ, Napoli C, Croce CM (2001) Heart-targeted overexpression of Caspase3 in mice increases infarct size and depresses cardiac function. PNAS 98:9977–9982

  26. Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619–642

    Article  CAS  PubMed  Google Scholar 

  27. Dragovich T, Rudin CM, Thompson CB (1988) Signal transduction pathways that regulate cell survival and cell death. Oncogene 17:3207–3213

  28. Nuñez G, Benedict MA, Hu Y, Inohara N (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17:3237–3245

  29. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312

  30. Satoh K, Gotoh T, Yamashita K (2000) Morphological effects of an anabolic steroid on muscle fibres of the diaphragm in mice.  Journal of Electron Microscopy 49:531–538

  31. Ostrander EA, Huson HJ, Ostrander GK (2009) Genetics of Athletic Performance Annu. Rev. Genomics Hum Genet 10:407–429

  32. Mills CD, Ley K (2014)  M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun 6:716–726

  33. Nahrendorf M,  Swirski FK (2013)  Monocyte and Macrophage Heterogeneity in the Heart. Circulation Research 112:1624–1633

  34. D’Ascenzo S, Millimaggi D, Di Massimo C, Saccani-Jotti G, Botrè F, Carta G, Tozzi-Ciancarelli MG, Pavan A, Dolo V (2007) Detrimental effects of anabolic steroids on human endothelial cells. Toxicology Letters 169:129–136

  35. Riezzo I, De Carlo D, Neri M, Nieddu A, Turillazzi E, Fineschi V (2011) Heart disease induced by AAS abuse, using experimental mice/rats models and the role of exercise-induced cardiotoxicity. Mini Rev Med Chem  11:409–424

  36. Frati P, Busardò F, Cipolloni L, Dominicis ED, Fineschi V (2015) Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings Curr Neuropharmacol. 13(1):146–159

Download references

Acknowledgements

Authors acknowledge Noemi Panebianco and Emi Shimada for their outstanding technical work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rossana Cecchi.

Ethics declarations

The histological staining was performed on human specimens used for forensic reasons.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cecchi, R., Muciaccia, B., Ciallella, C. et al. Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study. Int J Legal Med 131, 1589–1595 (2017). https://doi.org/10.1007/s00414-017-1589-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-017-1589-3

Keywords

Navigation